Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v1-EN
Language French English
Date Updated 2020-01-24 2019-11-28
Drug Identification Number 02327570 02327570
Brand name ACT OLANZAPINE ODT ACT OLANZAPINE ODT
Common or Proper name ACT-OLANZAPINE 10MG OD TAB ACT-OLANZAPINE 10MG OD TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients OLANZAPINE OLANZAPINE
Strength(s) 10MG 10MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 30UD 30UD
ATC code N05AH N05AH
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2019-11-28 2019-11-28
Estimated end date Unknown
Actual end date 2019-12-05
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Item is discontinued - Transitioning to TEVA SKU Item is to be discontinued - Transitioning to TEVA SKU
Health Canada comments